France · Delayed Price · Currency is EUR Aelis Farma Statistics
Total Valuation
Aelis Farma has a market cap or net worth of EUR 11.90 million. The enterprise value is 9.66 million.
| Market Cap | 11.90M |
| Enterprise Value | 9.66M |
Important Dates
The last earnings date was Tuesday, September 15, 2026.
| Earnings Date | Sep 15, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Aelis Farma has 13.60 million shares outstanding. The number of shares has increased by 0.46% in one year.
| Current Share Class | 13.60M |
| Shares Outstanding | 13.60M |
| Shares Change (YoY) | +0.46% |
| Shares Change (QoQ) | -0.30% |
| Owned by Insiders (%) | 38.32% |
| Owned by Institutions (%) | 2.94% |
| Float | 4.04M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 5.43 |
| PB Ratio | 5.15 |
| P/TBV Ratio | 5.61 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 4.41 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 9.80, with a Debt / Equity ratio of 1.89.
| Current Ratio | 9.80 |
| Quick Ratio | 9.48 |
| Debt / Equity | 1.89 |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.31 |
| Interest Coverage | -14.01 |
Financial Efficiency
Return on equity (ROE) is -112.53% and return on invested capital (ROIC) is -6,332.39%.
| Return on Equity (ROE) | -112.53% |
| Return on Assets (ROA) | -23.40% |
| Return on Invested Capital (ROIC) | -6,332.39% |
| Return on Capital Employed (ROCE) | -58.80% |
| Weighted Average Cost of Capital (WACC) | 7.17% |
| Revenue Per Employee | 137,000 |
| Profits Per Employee | -296,313 |
| Employee Count | 16 |
| Asset Turnover | 0.18 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Aelis Farma has paid 294,000 in taxes.
| Income Tax | 294,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -30.56% in the last 52 weeks. The beta is 0.62, so Aelis Farma's price volatility has been lower than the market average.
| Beta (5Y) | 0.62 |
| 52-Week Price Change | -30.56% |
| 50-Day Moving Average | 0.99 |
| 200-Day Moving Average | 1.18 |
| Relative Strength Index (RSI) | 33.07 |
| Average Volume (20 Days) | 14,700 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Aelis Farma had revenue of EUR 2.19 million and -4.74 million in losses. Loss per share was -0.35.
| Revenue | 2.19M |
| Gross Profit | 3.58M |
| Operating Income | -4.50M |
| Pretax Income | -4.45M |
| Net Income | -4.74M |
| EBITDA | -4.40M |
| EBIT | -4.50M |
| Loss Per Share | -0.35 |
Balance Sheet
The company has 6.62 million in cash and 4.38 million in debt, with a net cash position of 2.24 million or 0.16 per share.
| Cash & Cash Equivalents | 6.62M |
| Total Debt | 4.38M |
| Net Cash | 2.24M |
| Net Cash Per Share | 0.16 |
| Equity (Book Value) | 2.31M |
| Book Value Per Share | 0.17 |
| Working Capital | 6.94M |
Cash Flow
| Operating Cash Flow | -3.34M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 93,000 |
| Net Borrowing | -753,000 |
| Free Cash Flow | -3.34M |
| FCF Per Share | -0.25 |
Margins
Gross margin is 163.46%, with operating and profit margins of -205.11% and -216.29%.
| Gross Margin | 163.46% |
| Operating Margin | -205.11% |
| Pretax Margin | -202.87% |
| Profit Margin | -216.29% |
| EBITDA Margin | -200.87% |
| EBIT Margin | -205.11% |
| FCF Margin | n/a |
Dividends & Yields
Aelis Farma does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -0.46% |
| Shareholder Yield | -0.46% |
| Earnings Yield | -39.85% |
| FCF Yield | -28.03% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Aelis Farma has an Altman Z-Score of 1.11 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.11 |
| Piotroski F-Score | 4 |